AAAAAA
Results: 26-50/146
Authors:
GRANT S
NOBLE S
WOODS A
MURDOCH J
DAVIDSON A
Citation: S. Grant et al., ASSESSMENT OF INTUBATING CONDITIONS IN ADULTS AFTER INDUCTION WITH PROPOFOL AND VARYING DOSES OF REMIFENTANIL, British Journal of Anaesthesia, 81(4), 1998, pp. 540-543
Authors:
WANG SJ
GUO CY
CASTILLO A
DENT P
GRANT S
Citation: Sj. Wang et al., EFFECT OF BRYOSTATIN-1 ON TAXOL-INDUCED APOPTOSIS AND CYTOTOXICITY INHUMAN LEUKEMIA-CELLS (U937), Biochemical pharmacology, 56(5), 1998, pp. 635-644
Authors:
CANVIN J
GRANT S
FREESTONE P
TOTH I
TRINEI M
MODHA K
CELLIER D
NORRIS V
Citation: J. Canvin et al., RAPID GROWTH MUTANTS OF ESCHERICHIA-COLI, Acta biotheoretica, 46(2), 1998, pp. 161-166
Authors:
BARTIMOLE TM
VRANA JA
FREEMERMAN AJ
JARVIS WD
REED JC
BOISE LH
GRANT S
Citation: Tm. Bartimole et al., MODULATION OF THE EXPRESSION OF BCL-2 AND RELATED PROTEINS IN HUMAN LEUKEMIA-CELLS BY PROTEIN-KINASE-C ACTIVATORS - RELATIONSHIP TO EFFECTSON 1-[BETA-D-ARABINOFURANOSYL]CYTOSINE-INDUCED APOPTOSIS, Cell death and differentiation, 4(4), 1997, pp. 294-303
Authors:
BARTIMOLE TM
VRANA JA
FREEMERMAN AJ
JARVIS WD
REED JC
BOISE LH
GRANT S
Citation: Tm. Bartimole et al., MODULATION OF THE EXPRESSION OF BCL-2 AND RELATED PROTEINS IN HUMAN LEUKEMIA-CELLS BY PROTEIN-KINASE-C ACTIVATORS - RELATIONSHIP TO EFFECTSON 1-[BETA-D-ARABINOFURANOSYL]CYTOSINE-INDUCED APOPTOSIS, Cell death and differentiation, 4(4), 1997, pp. 294-303
Authors:
BUZEK J
KOUTNIKOVA H
HOUBEN A
RIHA K
JANOUSEK B
SIROKY J
GRANT S
VYSKOT B
Citation: J. Buzek et al., ISOLATION AND CHARACTERIZATION OF X-CHROMOSOME-DERIVED DNA-SEQUENCES FROM A DIOECIOUS PLANT MELANDRIUM-ALBUM, Chromosome research, 5(1), 1997, pp. 57-65
Authors:
GRANT S
STEEDS R
CHANNER K
Citation: S. Grant et al., PREDICTING ADVERSE CARDIAC EVENTS AFTER MYOCARDIAL-INFARCTION AND THROMBOLYSIS - STUDY DOES NOT JUSTIFY REPLACEMENT OF EXERCISE TESTING WITH RADIONUCLIDE IMAGING, BMJ. British medical journal, 314(7075), 1997, pp. 225-226
Authors:
BOLD J
GRANT S
Citation: J. Bold et S. Grant, CONTINGENT BOUNDARIES - THE CHANNEL-TUNNEL RAIL LINK CONSIDERED AS ANARCHITECTURAL ENSEMBLE, Transactions of the Ancient Monuments Society, 41, 1997, pp. 59-73
Authors:
EICHBERGER J
GRANT S
Citation: J. Eichberger et S. Grant, DYNAMICALLY CONSISTENT PREFERENCES WITH QUADRATIC BELIEFS, Journal of risk and uncertainty, 14(2), 1997, pp. 189-207
Authors:
SHIRLEY JS
MARTIN M
GRANT S
OCONNOR RW
RAVEN PB
Citation: Js. Shirley et al., CHANGES IN HUMAN BETA-ADRENERGIC-RECEPTOR DENSITY IN PERIPHERAL MONONUCLEAR LEUKOCYTES IN RESPONSE TO CHRONIC EXERCISE, The FASEB journal, 11(3), 1997, pp. 294-294
Authors:
FREEMERMAN AJ
VRANA JA
TOMBES RM
JIANG H
CHELLAPPAN SP
FISHER PB
GRANT S
Citation: Aj. Freemerman et al., EFFECTS OF ANTISENSE P21 (WAF1 CIP1/MDA6) EXPRESSION ON THE INDUCTIONOF DIFFERENTIATION AND DRUG-MEDIATED APOPTOSIS IN HUMAN MYELOID-LEUKEMIA CELLS (HL-60)/, Leukemia, 11(4), 1997, pp. 504-513
Authors:
LEMBICZ NK
GRANT S
CLEGG W
GRIFFIN RJ
HEATH SL
GOLDING BT
Citation: Nk. Lembicz et al., FACILITATION OF DISPLACEMENTS AT THE 6-POSITION OF PURINES BY THE USEOF 1,4-DIAZABICYCLO[2.2.2]OCTANE AS LEAVING GROUP, Journal of the Chemical Society. Perkin transactions. I, (3), 1997, pp. 185-186
Authors:
LEMBICZ NK
GRANT S
CLEGG W
GRIFFIN RJ
HEATH SL
GOLDING BT
Citation: Nk. Lembicz et al., FACILITATION OF DISPLACEMENTS AT THE 6-POSITION OF PURINES BY THE USEOF 1,4-DIAZABICYCLO[2.2.2]OCTANE AS LEAVING GROUP (VOL 1, PG 185, 1997), Journal of the Chemical Society. Perkin transactions. I, (23), 1997, pp. 3573-3573
Authors:
VANOS WAA
EDELMAN DA
RHEMREV PER
GRANT S
Citation: Waa. Vanos et al., ORAL-CONTRACEPTIVES AND BREAST-CANCER RISK, Advances in contraception, 13(1), 1997, pp. 63-69
Authors:
GRANT S
Citation: S. Grant, SLAVE TAKEOVER, New scientist, 154(2088), 1997, pp. 49-49
Authors:
CHEFER SI
MORRIS ED
WONG DF
INGRAM DK
ROTH G
LANE M
MUZIC RF
GRANT S
WEYL L
MATOCHIK J
VILLEMAGNE V
YOKOI F
DANNALS RF
LONDON ED
Citation: Si. Chefer et al., CONSIDERATIONS FOR MEASURING DOPAMINE BINDING POTENTIAL WITH PET IN THE STRIATA OF PRIMATES SMALLER THAN HUMANS, The Journal of nuclear medicine, 38(5), 1997, pp. 1141-1141
Authors:
GRANT S
Citation: S. Grant, COGNITIVE ARCHITECTURE FOR MODELING HUMAN ERROR IN COMPLEX DYNAMIC TASKS, Travail humain, 60(4), 1997, pp. 363-385
Authors:
JARVIS WD
FORNARI FA
AUER KL
FREEMERMAN AJ
SZABO E
BIRRER MJ
JOHNSON CR
BARBOUR SE
DENT P
GRANT S
Citation: Wd. Jarvis et al., COORDINATE REGULATION OF STRESS-ACTIVATED AND MITOGEN-ACTIVATED PROTEIN-KINASES IN THE APOPTOTIC ACTIONS OF CERAMIDE AND SPHINGOSINE, Molecular pharmacology, 52(6), 1997, pp. 935-947
Authors:
WANG SJ
VRANA JA
BARTIMOLE TM
FREEMERMAN AJ
JARVIS WD
KRAMER LB
KRYSTAL G
DENT P
GRANT S
Citation: Sj. Wang et al., AGENTS THAT DOWN-REGULATE OR INHIBIT PROTEIN-KINASE-C CIRCUMVENT RESISTANCE TO 1-BETA-D-ARABINOFURANOSYLCYTOSINE-INDUCED APOPTOSIS IN HUMANLEUKEMIA-CELLS THAT OVEREXPRESS BCL-2, Molecular pharmacology, 52(6), 1997, pp. 1000-1009
Authors:
GRANT S
Citation: S. Grant, HOSPITAL TIME - HOFFMAN,A, Journal of religion and health, 36(4), 1997, pp. 381-381
Authors:
GRANT S
QUIGGIN J
Citation: S. Grant et J. Quiggin, STRATEGIC TRADE-POLICY UNDER UNCERTAINTY - SUFFICIENT CONDITIONS FOR THE OPTIMALITY OF AD-VALOREM, SPECIFIC AND QUADRATIC TRADE TAXES, International economic review, 38(1), 1997, pp. 187-203
Authors:
JARVIS WD
AUER KL
SPECTOR M
KUNOS G
GRANT S
HYLEMON P
MIKKELSEN R
DENT P
Citation: Wd. Jarvis et al., POSITIVE AND NEGATIVE REGULATION OF JNK1 BY PROTEIN-KINASE-C AND P42(MAP KINASE) IN ADULT-RAT HEPATOCYTES, FEBS letters, 412(1), 1997, pp. 9-14
Authors:
BERNARDO NL
CHELLIAH J
DANGELO M
LOESSER KE
GRANT S
KUKREJA RC
Citation: Nl. Bernardo et al., THE 2ND WINDOW OF PROTECTION INDUCES EXPRESSION OF PROTOONCOGENE BCL2AND INHIBITS APOPTOSIS IN RABBIT HEART, Circulation, 96(8), 1997, pp. 3092-3092
Authors:
HORD J
SAGLAMER L
BIGBEE W
GRANT S
Citation: J. Hord et al., INCREASED SOMATIC MUTATION FREQUENCY IN ERYTHROCYTES FROM CHILDREN WITH HOMOZYGOUS HEMOGLOBIN-S DISEASE AND RETICULOCYTOSIS, Blood, 90(10), 1997, pp. 2811-2811
Authors:
GRANT S
ROBERTS J
TOMBES MB
KYLE B
Citation: S. Grant et al., PHASE-I TRIAL OF HIGH-DOSE ARA-C (18 GM M(2)/D) ADMINISTERED AS A 96-HOUR CONTINUOUS-INFUSION IN CONJUNCTION WITH DE-ESCALATING DOSES OF 2'-DEOXYCYTIDINE (IND-28108) IN PATIENTS WITH REFRACTORY HEMATOLOGIC MALIGNANCIES/, Blood, 90(10), 1997, pp. 3827-3827